Through biochemical and cellular studies, we demonstrate that USP11 stabilizes EGFR and TRAF6 by inhibiting their ubiquitination-mediated degradation, thereby promoting EGFR- and TLR-driven CRC progression, as illustrated in Fig. 8A. This evidence concerns the gene TRAF6 and colorectal carcinoma.